Exact Mass: 323.1692

Exact Mass Matches: 323.1692

Found 97 metabolites which its exact mass value is equals to given mass value 323.1692, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Paromamine

CHEMBL431061

C12H25N3O7 (323.1692)


   

Alloxydim

methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

C17H25NO5 (323.1733)


   

KANAMYCIN A RELATED COMPOUND 1

KANAMYCIN A RELATED COMPOUND 1

C12H25N3O7 (323.1692)


   

L-4-Hydroxyphenylglycyl-L-arginine

L-4-Hydroxyphenylglycyl-L-arginine; L-pHPg-L-Arg

C14H21N5O4 (323.1593)


   

(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine

3-[(10-hydroxydeca-2,8-dien-4-ynoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H25NO5 (323.1733)


(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is an acylcarnitine. More specifically, it is an (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Alanyl-2-(1,1-dimethyl-2-propenyl)dehydrotryptophan anhydride

Alanyl-2-(1,1-dimethyl-2-propenyl)dehydrotryptophan anhydride

C19H21N3O2 (323.1634)


   
   

5-Hydroxy-9-methylstreptimidone

5-Hydroxy-9-methylstreptimidone

C17H25NO5 (323.1733)


   
   
   
   

2-[6-(diethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-(diethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C14H21N5O4 (323.1593)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.710 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.712 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.707 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.708

   

12xi-hydroxy-14xi-methyl-(13xiH,15xiH)-15,20-dihydro-18,21-dinor-senecionane-11,16-dione|Crotananin|crotananine

12xi-hydroxy-14xi-methyl-(13xiH,15xiH)-15,20-dihydro-18,21-dinor-senecionane-11,16-dione|Crotananin|crotananine

C17H25NO5 (323.1733)


   

(-)-Neoechinulin A; Neoechinuline A

(-)-Neoechinulin A; Neoechinuline A

C19H21N3O2 (323.1634)


   

Macrophylline

Macrophylline

C17H25NO5 (323.1733)


   
   

dihydroneochinulin B

dihydroneochinulin B

C19H21N3O2 (323.1634)


   

tuberostemoline B

tuberostemoline B

C17H25NO5 (323.1733)


   
   

N-Acetyl-8alpha-hydroxyparthenolidine

N-Acetyl-8alpha-hydroxyparthenolidine

C17H25NO5 (323.1733)


   

isonaamine B|naamine A

isonaamine B|naamine A

C19H21N3O2 (323.1634)


   
   
   
   
   

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)Propanoic acid

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)Propanoic acid

C14H21N5O4 (323.1593)


   

neoechinulin A

cyclo-L-2-tert-DMA-Trp-L-Ala Delta(10,11)

C19H21N3O2 (323.1634)


   

(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

NCGC00347564-02!(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

C19H21N3O2 (323.1634)


   

Tobramycin rings B and C

Tobramycin rings B and C

C12H25N3O7 (323.1692)


   

C17H25NO5

NCGC00381005-01_C17H25NO5_

C17H25NO5 (323.1733)


   

Tobramycin, fragment AB or degraded

Tobramycin, fragment AB or degraded

C12H25N3O7 (323.1692)


   

(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based: Match]

NCGC00347564-02!(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based: Match]

C19H21N3O2 (323.1634)


   

(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based on: CCMSLIB00000845126]

NCGC00347564-02!(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based on: CCMSLIB00000845126]

C19H21N3O2 (323.1634)


   
   
   
   

Zolpidem Metabolite X-1

Zolpidem Metabolite X-1

C19H21N3O2 (323.1634)


   

Zolpidem Metabolite X-2

Zolpidem Metabolite X-2

C19H21N3O2 (323.1634)


   

CAY10449

4,5-dihydro-N-[4-[[4-(1-methylethoxy)phenyl]carbonyl]phenyl]-1H-imadazol-2-amine

C19H21N3O2 (323.1634)


   

1-(Isopropyl(dimethyl)-lambda~5~-azanyl)-3-(1-naphthyloxy)-2-propanol

1-(Isopropyl(dimethyl)-lambda~5~-azanyl)-3-(1-naphthyloxy)-2-propanol

C18H26ClNO2 (323.1652)


   

Boc-β-HomoThr(Bzl)-OH

Boc-β-HomoThr(Bzl)-OH

C17H25NO5 (323.1733)


   

4-(TERT-BUTOXYCARBONYL(4-METHOXYBENZYL)AMINO)BUTANOIC ACID

4-(TERT-BUTOXYCARBONYL(4-METHOXYBENZYL)AMINO)BUTANOIC ACID

C17H25NO5 (323.1733)


   

2-N-BOC-3-(4-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

2-N-BOC-3-(4-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C17H25NO5 (323.1733)


   

2-N-BOC-3-(3-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

2-N-BOC-3-(3-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C17H25NO5 (323.1733)


   

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONATE

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONATE

C17H25NO5 (323.1733)


   

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

C19H22BNO3 (323.1693)


   
   

Alcaftadine 3-Carboxylic Acid

Alcaftadine 3-Carboxylic Acid

C19H21N3O2 (323.1634)


   

5-(PIPERIDINE-1-SULFONYL)-2-PIPERIDIN-1-YL-PHENYLAMINE

5-(PIPERIDINE-1-SULFONYL)-2-PIPERIDIN-1-YL-PHENYLAMINE

C16H25N3O2S (323.1667)


   

alloxydim-sodium

alloxydim-sodium

C17H25NO5 (323.1733)


   

Boc-N-methyl-O-benzyl-L-threonine

Boc-N-methyl-O-benzyl-L-threonine

C17H25NO5 (323.1733)


   

4-(Phenylaminocarbonyl)benzeneboronic acid pinacol ester

4-(Phenylaminocarbonyl)benzeneboronic acid pinacol ester

C19H22BNO3 (323.1693)


   

(S)-tert-Butyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate

(S)-tert-Butyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate

C17H25NO5 (323.1733)


   

N,N-bis(trimethylsilyl)aminopropyltrimethoxysilane

N,N-bis(trimethylsilyl)aminopropyltrimethoxysilane

C12H33NO3Si3 (323.1768)


   

1-phenethyl-3,4-diphenyl-1H-pyrrole

1-phenethyl-3,4-diphenyl-1H-pyrrole

C24H21N (323.1674)


   

3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester

3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester

C19H21N3O2 (323.1634)


   

tert-Butyl (2R)-N-(2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl)carbamate

tert-Butyl (2R)-N-(2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl)carbamate

C17H25NO5 (323.1733)


   

2-Anilino-6-cyclohexylmethoxypurine

2-Anilino-6-cyclohexylmethoxypurine

C18H21N5O (323.1746)


   

1H-Imidazole-4-carboxamide, 1-((1R,2S)-2-hydroxy-1-(2-(1-naphthalenyl)ethyl)propyl)-

1H-Imidazole-4-carboxamide, 1-((1R,2S)-2-hydroxy-1-(2-(1-naphthalenyl)ethyl)propyl)-

C19H21N3O2 (323.1634)


   

Oxysonium

Oxysonium

C18H27O3S+ (323.1681)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

H-Pro-his-ala-OH

H-Pro-his-ala-OH

C14H21N5O4 (323.1593)


   

Deoxystreptamine-kanosaminide

Deoxystreptamine-kanosaminide

C12H25N3O7 (323.1692)


   

(6s)-2-Amino-6-(3-Methoxybiphenyl-3-Yl)-3,6-Dimethyl-5,6-Dihydropyrimidin-4(3h)-One

(6s)-2-Amino-6-(3-Methoxybiphenyl-3-Yl)-3,6-Dimethyl-5,6-Dihydropyrimidin-4(3h)-One

C19H21N3O2 (323.1634)


   

5-[(3-Aminopropyl)amino]-5-deoxyadenosine

5-[(3-Aminopropyl)amino]-5-deoxyadenosine

C13H21N7O3 (323.1706)


   

Akuammicine(1+)

Akuammicine(1+)

C20H23N2O2+ (323.1759)


An ammonium ion that is the conjugate acid of akuammicine, arising from the protonation of the tertiary amino group.

   

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,4-diaminobutyl)oxolane-3,4-diol

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,4-diaminobutyl)oxolane-3,4-diol

C13H21N7O3 (323.1706)


   

(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine

(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine

C17H25NO5 (323.1733)


   

1-[3-[(8-methyl-5H-pyrimido[5,4-b]indol-4-yl)amino]propyl]-2-pyrrolidinone

1-[3-[(8-methyl-5H-pyrimido[5,4-b]indol-4-yl)amino]propyl]-2-pyrrolidinone

C18H21N5O (323.1746)


   

N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide

N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide

C19H21N3O2 (323.1634)


   
   
   
   
   
   

5,5-dimethyl-2-[(5-methyl-4-phenyl-1H-pyrazol-3-yl)iminomethyl]cyclohexane-1,3-dione

5,5-dimethyl-2-[(5-methyl-4-phenyl-1H-pyrazol-3-yl)iminomethyl]cyclohexane-1,3-dione

C19H21N3O2 (323.1634)


   

(1S,12S,14R,15E)-15-ethylidene-17-methyl-3-aza-17-azoniapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylic acid

(1S,12S,14R,15E)-15-ethylidene-17-methyl-3-aza-17-azoniapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylic acid

C20H23N2O2+ (323.1759)


   

2-Deamino-2-hydroxyneamine

2-Deamino-2-hydroxyneamine

C12H25N3O7 (323.1692)


An amino cyclitol glycoside that is 2-deoxystreptamine in which the pro-R hydroxy group is substituted by a 6-amino-6-deoxy-alpha-D-glucosyl residue.

   

methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

C17H25NO5 (323.1733)


   

cyclo-L-2-tert-DMA-Trp-L-Ala Delta(10,11)

cyclo-L-2-tert-DMA-Trp-L-Ala Delta(10,11)

C19H21N3O2 (323.1634)


   
   
   

(3s,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3s,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C17H25NO5 (323.1733)


   

5-hydroxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

C19H21N3O2 (323.1634)


   

4-({2-imino-4-[(4-methoxyphenyl)methyl]-3-methylimidazol-1-yl}methyl)phenol

4-({2-imino-4-[(4-methoxyphenyl)methyl]-3-methylimidazol-1-yl}methyl)phenol

C19H21N3O2 (323.1634)


   

(3s)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

(3s)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

4-[(6e,8z)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(6e,8z)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

4-(2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-(2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

(3r,6e)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3r,6e)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)phenol

4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)phenol

C19H21N3O2 (323.1634)


   

(1s,4s,5r,6s,7r,17s)-7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1s,4s,5r,6s,7r,17s)-7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C17H25NO5 (323.1733)


   

4-[(2r,5r,6e,8e)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r,5r,6e,8e)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

4-[(2r,5e,7e)-2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r,5e,7e)-2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

4-(2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-(2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

(3r,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3r,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

4,5-bis[(4-methoxyphenyl)methyl]-1,3-dihydroimidazol-2-imine

4,5-bis[(4-methoxyphenyl)methyl]-1,3-dihydroimidazol-2-imine

C19H21N3O2 (323.1634)